title: Association of HLA class I antigen matching and early graft outcome in living donor kidney transplantation.
abstract: BACKGROUND
  HLA antigen matching often plays an important role in organ transplantation. As for HLA class I antigen matching, there are differences of opinion regarding its influence on the outcome of renal transplantations. The aim of this study was to evaluate the association of HLA class I antigen matching with early graft outcomes in living donor kidney transplantation.
  
  
  METHODS
  We evaluated graft outcomes in the first month of transplantation. Major events were slow graft function (serum creatinine > 250 micromol/L at the end of first week), delayed graft function (patients requiring dialysis in first week), and acute rejection episode. Graft outcomes were compared for normal renal function (NRF, serum creatinine < or = 175 micromol/L) impaired renal function (IRF, serum creatinine > 175 micromol/L) or impaired graft function due to an acute rejection episode (IGF).
  
  
  RESULTS
  The 115 subjects had a mean age of 29 +/- 8 years and their donors 38 +/- 11 years (P < .01). Immunosuppression included prednisolone, azathioprine, and cyclosporine. Parents, siblings, and others were kidney donors in 46%, 33%, and 21%, respectively. Comparisons between NRF/IRF (serum creatinine 133 +/- 24 vs 201 +/- 36 micromol/L, P < .01) and NGF/IGF (serum creatinine 146 +/- 44 vs 161 +/- 39 micromol/L, P < .05) showed no difference in number or pattern of HLA matching.
  
  
  CONCLUSIONS
  HLA class I antigen matching may not produce an added influence on early graft outcome among living donor kidney transplantations.
authors.affiliation: Department of Nephrology, SSMC&MH, Dhaka, Bangladesh. masud_1232001@yahoo.com
authors.forename: M M
authors.initials: MM
authors.lastname: Iqbal
authors.forename: R M
authors.initials: RM
authors.lastname: Hossain
authors.forename: H U
authors.initials: HU
authors.lastname: Rashid
authors.forename: M H
authors.initials: MH
authors.lastname: Rahman
authors.forename: M
authors.initials: M
authors.lastname: Datta
authors.forename: M S
authors.initials: MS
authors.lastname: Hassan
mesh_terms: D000328:Adult; D003404:Creatinine / Q000097:blood; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival / Q000276:immunology*; D015395:Histocompatibility Antigens Class I / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology*; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D010290:Parents; D035781:Siblings; D016896:Treatment Outcome
chemical_list: D015395:Histocompatibility Antigens Class I; D003404:Creatinine